Skip to main content
Log in

The Plasma Kinetics and Tissue Distribution of Enrofloxacin and its Metabolite Ciprofloxacin in the Muscovy Duck

  • Published:
Veterinary Research Communications Aims and scope Submit manuscript

Abstract

Intorre, L., Mengozzi, G., Bertini, S., Bagliacca, M., Luchetti, E. and Soldani, G., 1997. The plasma kinetics and tissue distribution of enrofloxacin and its metabolite ciprofloxacin in the Muscovy duck. Veterinary Research Communications, 21 (2), 127-136

The disposition and tissue distribution of enrofloxacin and of its main metabolite ciprofloxacin were investigated in ducks after oral or intramuscular administration of a single dose of 10 mg/kg enrofloxacin. Plasma and tissue concentrations were determined by a HPLC method. The peak concentrations of enrofloxacin after intramuscular administration (1.67 µg/ml at 0.9 h) were higher than after an oral dose (0.99 µg/ml at 1.38 h). The relative bioavailability of enrofloxacin after administration directly into the crop was 68%, while the metabolic conversion of enrofloxacin to ciprofloxacin was quite low (<10%) with both routes of administration. High tissue concentrations and high tissue:plasma concentration ratios were demonstrated for enrofloxacin and ciprofloxacin 24 h after treatment. It was concluded that a dose of 10 mg/kg per day provides serum and tissue concentrations sufficiently high to be effective in the control of many infectious diseases of ducks.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  • Altreuther, P., 1987. Data on chemistry and toxicology of Baytril. Veterinary Medicine Review, 2, 87–89

    Google Scholar 

  • Anadon, A., Martinez-Larranaga, M.R., Diaz, M.J., Bringas, P., Martinez, M.A., Fernandez-Cruz, M.L., Fernandez, M.C., Fernandez, R., 1995. Pharmacokinetics and residues of enrofloxacin in chickens. American Journal of Veterinary Research, 56, 501–506

    Google Scholar 

  • Baggot, J.D., 1992. Clinical pharmacokinetics in veterinary medicine. Clinical Pharmacokinetics, 22, 254–273

    Google Scholar 

  • Baggot, J.D., 1994. Principles of pharmacokinetics and their use in domestic animals. In: Proceedings of the Post-Congress Workshop of the Sixth International Congress of the European Association for Veterinary Pharmacology and Toxicology, Edinburgh, 1994, (Blackwell Scientific, Oxford), 1–47

    Google Scholar 

  • Bauditz, R., 1990. Enrofloxacin — Clinical evaluation in several animal species. In: F. Simon, P. Lees and G. Semjén (eds), Veterinary Pharmacology, Toxicology and Therapy in Food Producing Animals, (University of Veterinary Science, Unipharma Co. Ltd, Budapest), 21–26

    Google Scholar 

  • Bergan, T., Dalhoff, A. and Rohwedder, R., 1988. Pharmacokinetics of ciprofloxacin. Infection, 16(Supplement 1), 3–13

    Google Scholar 

  • Brown, S.A., 1996. Fluoroquinolones in animal health. Journal of Veterinary Pharmacology and Therapeutics, 19, 1–14

    Google Scholar 

  • Cabanes, A., Arboix, M., Anton, J.M.G. and Reig, F., 1992. Pharmacokinetics of enrofloxacin after intravenous and intramuscular injection in rabbits. American Journal of Veterinary Research, 53, 2090–2093

    Google Scholar 

  • Chu, D.T.W. and Fernandes, P.B., 1989. Structure-activity relationships of the fluoroquinolones. Antimicrobial Agents and Chemotherapy, 33, 131–135

    Google Scholar 

  • Dorrestein, G.M., 1991. The pharmacokinetics of avian therapeutics. Veterinary Clinics of North America, 21, 1241–1264

    Google Scholar 

  • Dorrestein, G.M. and Verburg, E., 1990. Pharmacokinetics of enrofloxacin in homing-pigeons. In: F. Simon, P. Lees and G. Semjén (eds), Veterinary Pharmacology, Toxicology and Therapy in Food Producing Animals, (University of Veterinary Science, Unipharma Co. Ltd, Budapest), 27–30

    Google Scholar 

  • Flammer, K., Aucoin, D.P. and Whitt, D.A., 1991. Intramuscular and oral disposition of enrofloxacin in African grey parrots following single and multiple doses. Journal of Veterinary Pharmacology and Therapeutics, 14, 359–366

    Google Scholar 

  • Froyman, R., Scheer, M. and De Jong, A., 1994. Serum kinetics of enrofloxacin in Pekin ducks during drinking-water medication and Baytril 10% oral solution. In: Proceedings of the Sixth International Congress of the European Association for Veterinary Pharmacology and Toxicology, Edinburgh, 1994, (Blackwell Scientific, Oxford), 236–237

    Google Scholar 

  • Gibaldi, M. and Perrier, D., 1982. Pharmacokinetics, 2nd edn, (Marcel Dekker, New York), 409–457

    Google Scholar 

  • Gicquel, M., Renard, L., Laurentie, M. and Sanders, P., 1994. Pharmacodynamic model of antimicrobial activity of enrofloxacin and ciprofloxacin. In: Proceedings of the Sixth International Congress of the European Association for Veterinary Pharmacology and Toxicology, Edinburgh, 1994, (Blackwell Scientific, Oxford), 229–230

    Google Scholar 

  • Hooper, D.C. and Wolfson, J.S., 1991. Fluoroquinolone antimicrobial agents. New England Journal of Medicine, 7, 384–394

    Google Scholar 

  • Kung, K., Riond, I.-L. and Wanner, M., 1993. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. Journal of Veterinary Pharmacology and Therapeutics, 16, 462–468

    Google Scholar 

  • Richez, P., Dellac, B. and Froyman, R., 1994. Pharmacokinetics and bioavailability of enrofloxacin in pigs after single and repeated in-feed medication with Baytril L.F.R. 2.5%. In: Proceedings of the Sixth International Congress of the European Association for Veterinary Pharmacology and Toxicology, Edinburgh, 1994, (Blackwell Scientific, Oxford), 207–208

    Google Scholar 

  • Scheer, M., 1987a. Concentrations of active ingredient in the serum and in tissues after oral and parenteral administration of Baytril. Veterinary Medicine Review, 2, 104–118

    Google Scholar 

  • Scheer, M., 1987b. Studies on the antimicrobial activity of Baytril. Veterinary Medicine Review, 2, 90–99

    Google Scholar 

  • Scheer, M., 1990. Enrofloxacin (Baytril) microbiological profile and pharmacokinetics in several species of animal. In: F. Simon, P. Lees and G. Semjén (eds), Veterinary Pharmacology, Toxicology and Therapy in Food Producing Animals, (University of Veterinary Science, Unipharma Co. Ltd, Budapest), 15–20

    Google Scholar 

  • Stipkovits, L., 1988. Studies on the efficacy of Baytril in chicks after experimental infection with Mycoplasma gallisepticum and E. coli. Veterinary Medicine Review, 59, 103–107

    Google Scholar 

  • Tyczkowska, K., Hedeen, K.M., Aucoin, D.P. and Aronson, A.L., 1989. High performance liquid chromatographic method for the simultaneous determination of enrofloxacin and its primary metabolite ciprofloxacin in canine serum and prostatic tissue. Journal of Chromatography, 493, 337–346

    Google Scholar 

  • Winer, B.J., 1971. In: Statistical Principles in Experimental Design, 2nd edn, (McGraw-Hill, New York), 201–205

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Intorre, L., Mengozzi, G., Bertini, S. et al. The Plasma Kinetics and Tissue Distribution of Enrofloxacin and its Metabolite Ciprofloxacin in the Muscovy Duck. Vet Res Commun 21, 127–136 (1997). https://doi.org/10.1023/A:1005773603905

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005773603905

Navigation